Add BrightSurf on Google Email

Long term use of anti-acid drugs may not increase stomach cancer risk

Researchers found no association between long term use of proton pump inhibitors and increased risk of stomach cancer. The study, which analyzed data from five Nordic countries over 26 years, suggests that patients needing long term proton pump inhibitor therapy may not need to worry about a higher risk of stomach cancer.

SourceBMJ Group·JournalThe BMJ·TypeObservational study·DateJan 21, 2026

Turmeric may be as good for treating indigestion as drug to curb excess stomach acid

A study of 151 patients with functional dyspepsia found that turmeric's curcumin was as effective as omeprazole in reducing symptoms after 28 days. Patients who took the combination treatment showed stronger improvements after 56 days, suggesting curcumin may be a viable alternative to conventional drugs.

SourceBMJ Group·JournalBMJ Evidence-Based Medicine·TypeRandomized controlled/clinical trial·DateSep 11, 2023

Antacid monotherapy more effective in relieving epigastric pain than in combination with lidocain

A double-blind, randomized clinical trial found antacid monotherapy to be the most palatable solution and had fewer side effects compared to antacid/lidocaine combinations. Antacid monotherapy was also found to be equally efficacious in relieving epigastric pain as lidocaine/antacid combination therapy.

SourceSociety for Academic Emergency Medicine·JournalAcademic Emergency Medicine·DateSep 28, 2020